Literature DB >> 17070182

Estrogenic ovulatory dysfunction or functional female hyperandrogenism: an argument to discard the term polycystic ovary syndrome.

Millie Behera1, Thomas Price, David Walmer.   

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders seen among reproductive-age women, with a prevalence of 4%-9% depending on the criteria used to define the syndrome. The diagnostic criteria for PCOS have been surprisingly controversial and confusing for patients, clinicians, and researchers. We believe that the confusion surrounding PCOS arises almost entirely because its name refers to a trait that is inconsistently present and irrelevant to both the etiology and the treatment of the disorder. We suggest that merely abandoning the term PCOS will cure much of what has ailed us for decades and allow us to focus on the etiology and treatment of the causes of what the experts in this field have come to recognize as functional female hyperandrogenism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070182     DOI: 10.1016/j.fertnstert.2006.06.048

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Polycystic ovary syndrome: what's in a name?

Authors:  Ricardo Azziz
Journal:  J Clin Endocrinol Metab       Date:  2014-02-03       Impact factor: 5.958

Review 2.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 3.  Polycystic Ovarian Syndrome: Is It Time to Rename PCOS to HA-PODS?

Authors:  Suvarna Satish Khadilkar
Journal:  J Obstet Gynaecol India       Date:  2016-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.